Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) had a loss and missed Wall Street’s expectations ... Click here for our fresh Feature Stock Pick now! Results: Adjusted Earnings Per Share decreased to $-0.66 in the quarter versus EPS of …
AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for …
Despite an impressive rally yesterday with a 32 percent gain on its share price, Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) took a dive today. The company’s stock dropped nearly 19 percent during the trading session, as the …
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)'s stock had its "hold" rating reiterated by stock analysts at Cowen and Company in a note issued to investors on Wednesday. They presently have a $1.50 target price on the …
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. The results of the Federal Reserve's June meeting were not a surprise. The central bank left rates unchanged …
LONDON--(Marketwire - Dec 20, 2012) - Wall Street Active pro-traders will be assisting investors today on LPX, LYG, BC and AEGR, and provide insight based on their extensive experience so that you can boost your stock portfolio on the …
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that …
AOL5d
AEGR closed at $10.41 and rose 15.5% on December 21. However, the stock was still trading below its 100-day moving average. Year-to-date, AEGR has returned -50.3%. It recorded trading volumes of ~1.8 million shares traded for the day. …
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that …
After terminating 25 percent of its workforce two months ago due to lagging sales of Juxtapid, Aegerion Pharmaceuticals, Inc. (AEGR) has entered into a merger ... each outstanding share of Aegerion common stock will be exchanged for …